Alyeska Investment Group, L.P.

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 1453072 CHICAGO, IL

Position in PRAX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$27,066,432

+$3,811,403 QoQ

Shares Held

80,846

+12.0% QoQ

Ownership

0.290%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#52

of 308 holders

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $989,063,778 across 83 Biotechnology names. PRAX ranks #8 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	659,279	$123,469,771
2	IONS	Ionis Pharmaceuticals Inc	1,417,916	$112,426,559
3	PTGX	Protagonist Therapeutics, Inc	889,298	$109,010,148
4	XENE	Xenon Pharmaceuticals Inc.	697,692	$42,112,689
5	MRNA	Moderna, Inc.	560,819	$39,274,154
6	KYMR	Kymera Therapeutics, Inc.	276,455	$31,701,094
7	LBRX	Lb Pharmaceuticals Inc	863,947	$28,039,399
8	PRAX	Praxis Precision Medicines, Inc. This page	80,846	$27,066,432

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$27,066,432	80,846	+12.0%	Shares	Sole	2026-08-14
2026-03-31	$23,255,029	72,178	-3.0%	Shares	Sole	2026-05-15
2025-12-31	$21,921,582	74,376	-47.4%	Shares	Sole	2026-02-13
2025-09-30	$7,500,348	141,516	+13.2%	Shares	Sole	2025-11-17
2025-06-30	$5,256,250	125,000	-16.7%	Shares	Sole	2025-08-14
2025-03-31	$5,680,500	150,000	-33.9%	Shares	Sole	2025-05-15
2024-12-31	$17,453,604	226,788	+807.2%	Shares	Sole	2025-02-14
2024-03-31	$1,525,500	25,000	-66.7%	Shares	Sole	2024-05-15
2021-06-30	$1,371,000	75,000	0.0%	Shares	Sole	2021-08-16
2020-12-31	$4,126,500	75,000	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.